| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8389277 | Meta Gene | 2016 | 10 Pages |
Abstract
Adding anti-EGFR moAb as first-line treatment in RAS-wt mCRC prolonged OS. Whether BRAF mutation is a predictive marker to anti-EGFR moAb is not clear.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry, Genetics and Molecular Biology (General)
Authors
Mingyi Zhou, Ping Yu, Kezuo Hou, Lingyu Fu, Ying Chen, Jinglei Qu, Xiujuan Qu, Yunpeng Liu, Jingdong Zhang,